Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Point-of-Care Early Infant Diagnosis Improves Adherence to the Testing Algorithm in Kenya.

Odhiambo CO, Githuka G, Bowen N, Kingwara L, Onsase J, Ochuka B, Waweru M, Masaba R, Matu L, Mwangi E, Cohn J.

J Int Assoc Provid AIDS Care. 2020 Jan-Dec;19:2325958220906030. doi: 10.1177/2325958220906030.

2.

Proteomics-Metabolomics Combined Approach Identifies Peroxidasin as a Protector against Metabolic and Oxidative Stress in Prostate Cancer.

Dougan J, Hawsawi O, Burton LJ, Edwards G, Jones K, Zou J, Nagappan P, Wang G, Zhang Q, Danaher A, Bowen N, Hinton C, Odero-Marah VA.

Int J Mol Sci. 2019 Jun 21;20(12). pii: E3046. doi: 10.3390/ijms20123046.

3.

CCAAT-displacement protein/cut homeobox transcription factor (CUX1) represses estrogen receptor-alpha (ER-α) in triple-negative breast cancer cells and can be antagonized by muscadine grape skin extract (MSKE).

Burton LJ, Hawsawi O, Sweeney J, Bowen N, Hudson T, Odero-Marah V.

PLoS One. 2019 Apr 9;14(4):e0214844. doi: 10.1371/journal.pone.0214844. eCollection 2019.

4.

Essential role of JunD in cell proliferation is mediated via MYC signaling in prostate cancer cells.

Elliott B, Millena AC, Matyunina L, Zhang M, Zou J, Wang G, Zhang Q, Bowen N, Eaton V, Webb G, Thompson S, McDonald J, Khan S.

Cancer Lett. 2019 Apr 28;448:155-167. doi: 10.1016/j.canlet.2019.02.005. Epub 2019 Feb 11.

PMID:
30763715
5.

Racial/ethnic measurement invariance of the School Success Profile (SSP)'s future orientation scale.

Xiao Y, Bowen NK, Lindsey MA.

J Sch Psychol. 2018 Dec;71:85-107. doi: 10.1016/j.jsp.2018.10.003. Epub 2018 Nov 16.

PMID:
30463672
6.

Association of Epithelial Mesenchymal Transition with prostate and breast health disparities.

Burton LJ, Hawsawi O, Loyd Q, Henderson V, Howard S, Harlemon M, Ragin C, Roberts R, Bowen N, Gacii A, Odero-Marah V.

PLoS One. 2018 Sep 10;13(9):e0203855. doi: 10.1371/journal.pone.0203855. eCollection 2018.

7.

Discovery of Mcl-1 inhibitors based on a thiazolidine-2,4-dione scaffold.

Whiting E, Raje MR, Chauhan J, Wilder PT, Van Eker D, Hughes SJ, Bowen NG, Vickers GEA, Fenimore IC, Fletcher S.

Bioorg Med Chem Lett. 2018 Feb 1;28(3):523-528. doi: 10.1016/j.bmcl.2017.11.023. Epub 2017 Dec 12.

PMID:
29329659
8.

The immunoregulatory role of alpha enolase in dendritic cell function during Chlamydia infection.

Ryans K, Omosun Y, McKeithen DN, Simoneaux T, Mills CC, Bowen N, Eko FO, Black CM, Igietseme JU, He Q.

BMC Immunol. 2017 May 19;18(1):27. doi: 10.1186/s12865-017-0212-1.

9.

Reconstitution of Saccharomyces cerevisiae DNA polymerase ε-dependent mismatch repair with purified proteins.

Bowen N, Kolodner RD.

Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):3607-3612. doi: 10.1073/pnas.1701753114. Epub 2017 Mar 6.

10.

Measuring dimensions of intergenerational contact: factor analysis of the Queen's University Scale.

Jarrott SE, Weaver RH, Bowen NK, Wang N.

Aging Ment Health. 2018 Apr;22(4):568-573. doi: 10.1080/13607863.2017.1280769. Epub 2017 Jan 27.

PMID:
28128665
11.

Undisclosed HIV infection and antiretroviral therapy use in the Kenya AIDS indicator survey 2012: relevance to national targets for HIV diagnosis and treatment.

Kim AA, Mukui I, Young PW, Mirjahangir J, Mwanyumba S, Wamicwe J, Bowen N, Wiesner L, Ng'ang'a L, De Cock KM; KAIS Study Group.

AIDS. 2016 Nov 13;30(17):2685-2695.

12.

GLI pathogenesis-related 1 functions as a tumor-suppressor in lung cancer.

Sheng X, Bowen N, Wang Z.

Mol Cancer. 2016 Mar 18;15:25. doi: 10.1186/s12943-016-0508-4.

13.

Highly and moderately aggressive mouse ovarian cancer cell lines exhibit differential gene expression.

Du F, Li Y, Zhang W, Kale SP, McFerrin H, Davenport I, Wang G, Skripnikova E, Li XL, Bowen NJ, McDaniels LB, Meng YX, Polk P, Liu YY, Zhang QJ.

Tumour Biol. 2016 Aug;37(8):11147-11162. doi: 10.1007/s13277-015-4518-4. Epub 2016 Mar 2.

14.

Peri-stomal abdominal wall augmentation: Novel use of a pedicled antero-lateral thigh flap.

Warbrick-Smith J, Bowen N, Drew PJ.

J Plast Reconstr Aesthet Surg. 2015 Dec;68(12):e203-4. doi: 10.1016/j.bjps.2015.08.030. Epub 2015 Sep 3. No abstract available.

PMID:
26375460
15.

Activation of Saccharomyces cerevisiae Mlh1-Pms1 Endonuclease in a Reconstituted Mismatch Repair System.

Smith CE, Bowen N, Graham WJ 5th, Goellner EM, Srivatsan A, Kolodner RD.

J Biol Chem. 2015 Aug 28;290(35):21580-90. doi: 10.1074/jbc.M115.662189. Epub 2015 Jul 13.

16.

HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients.

Pannu V, Rida PC, Ogden A, Turaga RC, Donthamsetty S, Bowen NJ, Rudd K, Gupta MV, Reid MD, Cantuaria G, Walczak CE, Aneja R.

Oncotarget. 2015 Mar 20;6(8):6076-91.

17.

Prostate cancer epigenome.

Chinaranagari S, Sharma P, Bowen NJ, Chaudhary J.

Methods Mol Biol. 2015;1238:125-40. doi: 10.1007/978-1-4939-1804-1_7. Review.

18.

Rural neighborhoods and child aggression.

Bowen NK, Wretman CJ.

Am J Community Psychol. 2014 Dec;54(3-4):304-15. doi: 10.1007/s10464-014-9673-z.

PMID:
25205545
19.

KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries.

Pawar S, Donthamsetty S, Pannu V, Rida P, Ogden A, Bowen N, Osan R, Cantuaria G, Aneja R.

J Ovarian Res. 2014 May 12;7:53. doi: 10.1186/1757-2215-7-53. eCollection 2014.

20.

Inhibitor of differentiation 4 (ID4) inactivation promotes de novo steroidogenesis and castration-resistant prostate cancer.

Patel D, Knowell AE, Korang-Yeboah M, Sharma P, Joshi J, Glymph S, Chinaranagari S, Nagappan P, Palaniappan R, Bowen NJ, Chaudhary J.

Mol Endocrinol. 2014 Aug;28(8):1239-53. doi: 10.1210/me.2014-1100. Epub 2014 Jun 12.

21.

Mlh2 is an accessory factor for DNA mismatch repair in Saccharomyces cerevisiae.

Campbell CS, Hombauer H, Srivatsan A, Bowen N, Gries K, Desai A, Putnam CD, Kolodner RD.

PLoS Genet. 2014 May 8;10(5):e1004327. doi: 10.1371/journal.pgen.1004327. eCollection 2014 May.

22.

Mephedrone inhalation causes pneumomediastinum.

Graham R, Bowen N, Singh J.

BMJ Case Rep. 2014 Mar 10;2014. pii: bcr2014203704. doi: 10.1136/bcr-2014-203704.

23.

Mispair-specific recruitment of the Mlh1-Pms1 complex identifies repair substrates of the Saccharomyces cerevisiae Msh2-Msh3 complex.

Srivatsan A, Bowen N, Kolodner RD.

J Biol Chem. 2014 Mar 28;289(13):9352-64. doi: 10.1074/jbc.M114.552190. Epub 2014 Feb 18.

24.

Dominant mutations in S. cerevisiae PMS1 identify the Mlh1-Pms1 endonuclease active site and an exonuclease 1-independent mismatch repair pathway.

Smith CE, Mendillo ML, Bowen N, Hombauer H, Campbell CS, Desai A, Putnam CD, Kolodner RD.

PLoS Genet. 2013 Oct;9(10):e1003869. doi: 10.1371/journal.pgen.1003869. Epub 2013 Oct 31.

25.

Reconstitution of long and short patch mismatch repair reactions using Saccharomyces cerevisiae proteins.

Bowen N, Smith CE, Srivatsan A, Willcox S, Griffith JD, Kolodner RD.

Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18472-7. doi: 10.1073/pnas.1318971110. Epub 2013 Nov 1.

26.

Gene transfection enhanced by ultrasound exposure combined with drug treatment guided by gene chip analysis.

Liu Y, Bowen NJ, Matyunina L, McDonald J, Prausnitz MR.

Int J Hyperthermia. 2012;28(4):349-61. doi: 10.3109/02656736.2012.669513.

PMID:
22621736
27.

Isolation and characterization of stem-like cells from a human ovarian cancer cell line.

Wang L, Mezencev R, Bowen NJ, Matyunina LV, McDonald JF.

Mol Cell Biochem. 2012 Apr;363(1-2):257-68. doi: 10.1007/s11010-011-1178-6. Epub 2011 Dec 9.

PMID:
22160925
28.

Prediction of transposable element derived enhancers using chromatin modification profiles.

Huda A, Tyagi E, Mariño-Ramírez L, Bowen NJ, Jjingo D, Jordan IK.

PLoS One. 2011;6(11):e27513. doi: 10.1371/journal.pone.0027513. Epub 2011 Nov 7.

29.

Family-Faculty Trust As Measured with the ESSP.

Bower HA, Bowen NK, Powers JD.

Child Sch. 2011 Jul 1;33(3):158-167.

30.

Low effect sizes of evidence-based programs in school settings.

Powers JD, Bowen NK, Webber KC, Bowen GL.

J Evid Based Soc Work. 2011 Jul 29;8(4):397-415. doi: 10.1080/15433714.2011.534316.

PMID:
21827306
31.

Evidence for the complexity of microRNA-mediated regulation in ovarian cancer: a systems approach.

Shahab SW, Matyunina LV, Mezencev R, Walker LD, Bowen NJ, Benigno BB, McDonald JF.

PLoS One. 2011;6(7):e22508. doi: 10.1371/journal.pone.0022508. Epub 2011 Jul 21.

33.

Child-Report Data and Assessment of the Social Environment in Schools.

Bowen NK.

Res Soc Work Pract. 2011 Jul;21(4):476-486.

34.

Epigenetic regulation of transposable element derived human gene promoters.

Huda A, Bowen NJ, Conley AB, Jordan IK.

Gene. 2011 Apr 1;475(1):39-48. doi: 10.1016/j.gene.2010.12.010. Epub 2011 Jan 6.

PMID:
21215797
35.

Evidence-based programs in school settings: barriers and recent advances.

Powers JD, Bowen NK, Bowen GL.

J Evid Based Soc Work. 2010 Jul;7(4):313-31. doi: 10.1080/15433710903256807.

PMID:
20799130
36.

Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry.

Liu Y, Chen Y, Momin A, Shaner R, Wang E, Bowen NJ, Matyunina LV, Walker LD, McDonald JF, Sullards MC, Merrill AH Jr.

Mol Cancer. 2010 Jul 12;9:186. doi: 10.1186/1476-4598-9-186.

37.

Bifurcation and enhancement of autonomous-nonautonomous retrotransposon partnership through LTR Swapping in soybean.

Du J, Tian Z, Bowen NJ, Schmutz J, Shoemaker RC, Ma J.

Plant Cell. 2010 Jan;22(1):48-61. doi: 10.1105/tpc.109.068775. Epub 2010 Jan 15.

38.

Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells.

Bowen NJ, Walker LD, Matyunina LV, Logani S, Totten KA, Benigno BB, McDonald JF.

BMC Med Genomics. 2009 Dec 29;2:71. doi: 10.1186/1755-8794-2-71.

39.

A c-Myc regulatory subnetwork from human transposable element sequences.

Wang J, Bowen NJ, Mariño-Ramírez L, Jordan IK.

Mol Biosyst. 2009 Dec;5(12):1831-9. doi: 10.1039/B908494k. Epub 2009 Jul 21.

40.

Homogeneous and organized differentiation within embryoid bodies induced by microsphere-mediated delivery of small molecules.

Carpenedo RL, Bratt-Leal AM, Marklein RA, Seaman SA, Bowen NJ, McDonald JF, McDevitt TC.

Biomaterials. 2009 May;30(13):2507-15. doi: 10.1016/j.biomaterials.2009.01.007. Epub 2009 Jan 21.

41.

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.

Köbel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A, Prentice LM, Miller D, Santos J, Swenerton K, Gilks CB, Huntsman D.

PLoS Med. 2008 Dec 2;5(12):e232. doi: 10.1371/journal.pmed.0050232.

42.

Exaptation of protein coding sequences from transposable elements.

Bowen NJ, Jordan IK.

Genome Dyn. 2007;3:147-162. doi: 10.1159/000107609. Review.

PMID:
18753790
43.

Identification of metabolites with anticancer properties by computational metabolomics.

Arakaki AK, Mezencev R, Bowen NJ, Huang Y, McDonald JF, Skolnick J.

Mol Cancer. 2008 Jun 17;7:57. doi: 10.1186/1476-4598-7-57.

44.

LTR retrotransposons and the evolution of dosage compensation in Drosophila.

Matyunina LV, Bowen NJ, McDonald JF.

BMC Mol Biol. 2008 Jun 4;9:55. doi: 10.1186/1471-2199-9-55.

46.

The role of the NNP in facilitating family-centered care.

Bowen NC.

Neonatal Netw. 2007 Jul-Aug;26(4):271-2. No abstract available.

PMID:
17710962
47.

Evidence that p53-mediated cell-cycle-arrest inhibits chemotherapeutic treatment of ovarian carcinomas.

Moreno CS, Matyunina L, Dickerson EB, Schubert N, Bowen NJ, Logani S, Benigno BB, McDonald JF.

PLoS One. 2007 May 16;2(5):e441.

48.

Identification of candidate methylation-responsive genes in ovarian cancer.

Menendez L, Walker D, Matyunina LV, Dickerson EB, Bowen NJ, Polavarapu N, Benigno BB, McDonald JF.

Mol Cancer. 2007 Jan 25;6:10.

49.
50.

Emerging roles for PAX8 in ovarian cancer and endosalpingeal development.

Bowen NJ, Logani S, Dickerson EB, Kapa LB, Akhtar M, Benigno BB, McDonald JF.

Gynecol Oncol. 2007 Feb;104(2):331-7. Epub 2006 Oct 24.

PMID:
17064757

Supplemental Content

Support Center